Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort studySara Y. Tartof, John M. McLaughlin, Bradley K. Ackerson et al.|The Lancet|2021Cited by 1.3k
Effectiveness of a third dose of BNT162b2 mRNA COVID-19 vaccine in a large US health system: A retrospective cohort studySara Y. Tartof, John M. McLaughlin, Jeff Slezak et al.|The Lancet Regional Health - Americas|2022Cited by 117